AB-PINACA

From Wikipedia, the free encyclopedia
Jump to: navigation, search
AB-PINACA
AB-PINACA structure.png
Systematic (IUPAC) name
N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide
Clinical data
Legal status
?
Identifiers
CAS number 1445752-09-9 YesY
ATC code ?
ChemSpider 28537615
Chemical data
Formula C18H26N4O2 
Mol. mass 330.43 g/mol

AB-PINACA is a compound that was first identified as a component of synthetic cannabis products in Japan in 2012.[1] The pharmacological properties of this compound have not been formally studied or reported in the scientific literature, but it is presumably a cannabinoid agonist as it was found alongside a structurally related compound AB-FUBINACA which had previously been reported as a cannabinoid agonist in a 2009 Pfizer patent.[2][3]

See also[edit]

References[edit]

  1. ^ Uchiyama, N.; Matsuda, S.; Wakana, D.; Kikura-Hanajiri, R.; Goda, Y. (2012). "New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products". Forensic Toxicology 31: 93. doi:10.1007/s11419-012-0171-4.  edit
  2. ^ Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106980
  3. ^ Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982